Drug Approval | June 25, 2025
Lupin receives USFDA approval for Prucalopride Tablets
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Sun Pharma gets 8 observations from USFDA for Halol facility
The company received one observation in the Form-483
Subscribe To Our Newsletter & Stay Updated
